Biomarker analysis in patients with advanced gastric cancer treated with S-1 plus cisplatin chemotherapy: orotate phosphoribosyltransferase expression is associated with treatment outcomes Med Oncol (2011) 28:991?998

Three-weekly S-1 plus cisplatin chemotherapy as first-line treatment for advanced gastric cancer Med Oncol (2010) 27:992?997

Phase II study of biweekly S-1 and oxaliplatin combination chemotherapy in metastatic colorectal cancer and pharmacogenetic analysis Cancer Chemother Pharmacol (2011) 67:1323?1331

AmulticenterphaseIIstudyofgemcitabineandS-1combinationchemotherapyinpatientswithunresectablepancreaticcancer Cancer Chemother Pharmacol (2010) 65:527?536

Epidermalgrowthfactorreceptorintron1CAdinucleotiderepeatpolymorphismandsurvivalofadvancedgastriccancerpatientstreatedwithcetuximabplusmodifiedFOLFOX6CancerSci(2010)101:793?799

PhaseIIstudyandbiomarkeranalysisofcetuximabcombinedwithmodifiedFOLFOX6inadvancedgastriccancerBritishJournalofCancer(2009)100,298?304

Amulti-centerphaseIIstudyofS-1pluspaclitaxelasfirst-linetherapyforpatientswithadvancedorrecurrentunresectablegastriccancerCancer Chemother Pharmacol (2009) 63:1083?1090

A phase II Trial of S-1 and Cisplatin in Patients with Metastatic or Relapsed Biliary Tract Cancer Annals of Oncology 2008;19:99-103

Oxaliplatin, 5-FU, Folinic Acid as First-line Palliative Chemotherapy in Elderly Patients with Metastatic or Recurrent Gastric Cancer Cancer Res Treat 2007;39(3):99-103

Phase II Trial of Low-dose Paclitaxel and Cisplatin in Patients with Advanced Gastric Cancer Jpn J Clin Oncol 2005;35(12):720-6

Predictive and Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Non-Small-Cell Lung Cancer Patients Treated With Gefitinib J Clin Oncol 2005;23(11):2493-501

Reduced Dose Intensity FOLFOX-4 as First Line Palliative Chemotherapy in Elderly Patients with Advanced Colorectal Cancer J Korean Med Sci 2005;20: 806-10